Study identifies potential new drugs that can help treat depression and anxiety disorders without many of the adverse effects of other medications currently under evaluation.
Researchers shed light on how different SSRI antidepressants may work to help fight symptoms of depression in the brain.
Investigating how psychedelics such as psilocybin act on serotonin receptors, researchers shed new light on how the drugs affect consciousness and assist in treating a range of mental health disorders.
A newly developed vaccine blocks the ability of the opioid Fentanyl's ability to enter the brain, thus blocking the drug's "high".
Examining the gut microbiome of those with major depressive disorder, researchers identify the presence of the bacteria Faecalibacterium prausnitzii as being responsible for the functional discrepancies between healthy individuals and those with MDD.
Study reveals mindfulness-based stress reduction methods proved to be as effective as antidepressants for relieving symptoms for those with anxiety disorders.
Premenstrual dysphoric disorder (PMDD) is a severe mood disorder that affects one in twenty women. PMDD can have a debilitating impact on the lives of sufferers. Researchers investigate PMDD and evaluate treatment options for sufferers.
Study reveals the basic neurobiology of how psychedelics work at the chemical, molecular, neural, and network levels within the brain.
Effective neurochemical changes in the brain of those with social anxiety take different forms after SSRI treatment and cognitive behavioral therapy.
A new identifies a specific gene that regulates neural progenitor cell proliferation in response to lithium for those with bipolar depression.
Those with treatment-resistant depression showed significant improvement in symptoms and became more receptive to positive experiences following a one-week ketamine treatment regimen.
Study reveals a 44% reduction in suicidal events, including suicide attempts and self-harm, in depressed patients who took folic acid supplements.
